[{"NetIncomeLoss_2_Q2_USD":-47497000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":8.08,"GeneralAndAdministrativeExpense_2_Q2_USD":18662000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8998000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":77623132.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":84353438.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":5787000.0,"PreferredStockValueOutstanding_0_Q2_USD":0.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":431000.0,"ValueAddedTaxReceivableCurrent_0_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-222000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":122505000.0,"IncomeTaxesPaid_2_Q2_USD":92000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-86000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2290978.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-206000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-232000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1132000.0,"AssetsCurrent_0_Q2_USD":450266000.0,"OperatingLeaseExpense_2_Q2_USD":500000.0,"OperatingLeaseExpense_1_Q2_USD":300000.0,"OtherNoncashIncome_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":5971882.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":119000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":134000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1152000.0,"CommonStockSharesIssued_0_Q2_shares":97890705.0,"ProceedsFromContributedCapital_2_Q2_USD":217000.0,"Depreciation_2_Q2_USD":24000.0,"OperatingLeaseLiability_0_Q2_USD":3781000.0,"DeferredCosts_0_Q2_USD":0.0,"Liabilities_0_Q2_USD":15489000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":2800000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":587000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":28898000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":11976000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":14.27,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4116000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":394000.0,"RepaymentsOfConvertibleDebt_2_Q2_USD":0.0,"AccruedBonusesCurrent_0_Q2_USD":1339000.0,"PrepaidExpenseCurrent_0_Q2_USD":5854000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-5166000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":151000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":225000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":88000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":40000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2679000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":444372000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-21021000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-47703000.0,"ProceedsFromNotesPayable_2_Q2_USD":0.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":0.0,"Assets_0_Q2_USD":453895000.0,"CommonStockNoParValue_0_Q2_USD":0.0001,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":381903000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":-0.0019,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":-0.0018,"IncreaseDecreaseInDueToRelatedPartiesCurrent_2_Q2_USD":-149000.0,"ForeignCurrencyTransactionGainLossUnrealized_2_Q2_USD":206000.0,"CommonStockValue_0_Q2_USD":10000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":975000.0,"ConvertiblePreferredStockSharesReservedForFutureIssuance_0_Q2_shares":10000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-206000.0,"ShareBasedCompensation_2_Q2_USD":7342000.0,"WriteOffOfDeferredDebtIssuanceCost_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5834682.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":945851.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-138723000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":343801000.0,"CommonStockSharesOutstanding_0_Q2_shares":97890705.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_Q2_shares":226233.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":7.86,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3307000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-232000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38016000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1198000.0,"LiabilitiesCurrent_0_Q2_USD":12810000.0,"AccountsPayableCurrent_0_Q2_USD":5787000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":86000.0,"InterestExpense_2_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":444372000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":182000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":253000.0,"RelatedPartyTransactionAmountsOfTransaction_2_Q2_USD":500000.0,"RelatedPartyTransactionAmountsOfTransaction_1_Q2_USD":200000.0,"AdditionalPaidInCapital_0_Q2_USD":577341000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":42213.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingLeasePayments_2_Q2_USD":200000.0,"OperatingLeasePayments_1_Q2_USD":100000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":25646000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":136000.0,"NetIncomeLoss_1_Q2_USD":-20789000.0,"InterestExpense_1_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":438406000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.25,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.61,"OperatingLeaseRightOfUseAsset_0_Q2_USD":3493000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":11073439.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":14.86,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":16.05,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":23.26,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":335000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":47000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":4737000.0,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":5101557.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-47409000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-20749000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_2_Q2_USD":0.0,"IncomeTaxesReceivable_0_Q2_USD":40000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":4000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_0_Q2_shares":1800000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":3924000.0,"OperatingExpenses_1_Q2_USD":20974000.0,"OperatingExpenses_2_Q2_USD":47560000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1102000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":61738.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-232000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":47100000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7225000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":453895000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.31,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.51,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3307000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":772000.0,"Ticker":"IMVT","CIK":"1764013","name":"IMMUNOVANT, INC.","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201112"}]